ABBV Jan 2025 150.000 call
| Previous close | 47.77 |
| Open | 47.60 |
| Bid | 45.05 |
| Ask | 46.05 |
| Strike | 150.00 |
| Expiry date | 2025-01-17 |
| Day's range | 47.60 - 47.60 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.98k |
PR NewswireAllergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced that BOTOX® Cosmetic (onabotulinumtoxinA) is now available for the treatment of masseter muscle prominence (MMP) in China. The masseter is one of the muscles in the lower face involved in chewing, and prominence of the masseter muscle can result in a wide and square lower face shape1. BOTOX® Cosmetic was recently approved for the temporary improvement in the appearance of marked to very marked MMP in adults by the China Nationa
ZacksThe Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian
Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian are included in this Analyst Blog.
ZacksTop Stock Reports for Visa, AbbVie & Anheuser-Busch
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Anheuser-Busch InBev SA/NV (BUD), as well as two micro-cap stocks Servotronics, Inc. (SVT) and United-Guardian, Inc. (UG).
